001     141291
005     20240229112523.0
024 7 _ |a 10.1002/ijc.31928
|2 doi
024 7 _ |a pmid:30325019
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:49828197
|2 altmetric
037 _ _ |a DKFZ-2018-01811
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Campa, Daniele
|0 0000-0003-3220-9944
|b 0
245 _ _ |a Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study.
260 _ _ |a Bognor Regis
|c 2019
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1555398649_10187
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Telomere deregulation is a hallmark of cancer. Telomere length measured in lymphocytes (LTL) has been shown to be a risk marker for several cancers. For pancreatic ductal adenocarcinoma (PDAC) consensus is lacking whether risk is associated with long or short telomeres. Mendelian randomization approaches have shown that a score built from SNPs associated with LTL could be used as a robust risk marker. We explored this approach in a large scale study within the PANcreatic Disease ReseArch (PANDoRA) consortium. We analyzed 10 SNPs (ZNF676-rs409627, TERT-rs2736100, CTC1-rs3027234, DHX35-rs6028466, PXK-rs6772228, NAF1-rs7675998, ZNF208-rs8105767, OBFC1-rs9420907, ACYP2-rs11125529 and TERC-rs10936599) alone and combined in a LTL genetic score ('teloscore', which explains 2.2% of the telomere variability) in relation to PDAC risk in 2,374 cases and 4,326 controls. We identified several associations with PDAC risk, among which the strongest were with the TERT-rs2736100 SNP (OR = 1.54; 95%CI 1.35-1.76; p = 1.54x10-10 ) and a novel one with the NAF1-rs7675998 SNP (OR = 0.80; 95%CI 0.73-0.88; p = 1.87x10-6 , ptrend  = 3.27x10-7 ). The association of short LTL, measured by the teloscore, with PDAC risk reached genome-wide significance (p = 2.98x10-9 for highest vs. lowest quintile; p = 1.82x10-10 as a continuous variable). In conclusion, we present a novel genome-wide candidate SNP for PDAC risk (TERT-rs2736100), a completely new signal (NAF1-rs7675998) approaching genome-wide significance and we report a strong association between the teloscore and risk of pancreatic cancer, suggesting that telomeres are a potential risk factor for pancreatic cancer. This article is protected by copyright. All rights reserved.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Matarazzi, Martina
|0 P:(DE-He78)20cdd3e2d3e6f8de7b2b90ab138c7a88
|b 1
700 1 _ |a Greenhalf, William
|b 2
700 1 _ |a Bijlsma, Maarten
|b 3
700 1 _ |a Saum, Kai-Uwe
|0 P:(DE-He78)97343bbd9545a4b87574e74329dabfd1
|b 4
700 1 _ |a Pasquali, Claudio
|b 5
700 1 _ |a van Laarhoven, Hanneke
|b 6
700 1 _ |a Szentesi, Andrea
|b 7
700 1 _ |a Federici, Francesca
|b 8
700 1 _ |a Vodicka, Pavel
|b 9
700 1 _ |a Funel, Niccola
|b 10
700 1 _ |a Pezzilli, Raffaele
|b 11
700 1 _ |a Bueno-de-Mesquita, H Bas
|b 12
700 1 _ |a Vodickova, Ludmila
|b 13
700 1 _ |a Basso, Daniela
|b 14
700 1 _ |a Obazee, Ofure
|0 P:(DE-He78)ac7a26c496af814293aa74ab92d5f5b3
|b 15
|u dkfz
700 1 _ |a Hackert, Thilo
|b 16
700 1 _ |a Soucek, Pavel
|0 0000-0002-4294-6799
|b 17
700 1 _ |a Cuk, Katarina
|0 P:(DE-He78)0a8ada1f5d2ea05fc3af10cd808bfa9a
|b 18
700 1 _ |a Kaiser, Jörg
|b 19
700 1 _ |a Sperti, Cosimo
|b 20
700 1 _ |a Lovecek, Martin
|b 21
700 1 _ |a Capurso, Gabriele
|b 22
700 1 _ |a Mohelnikova-Duchonova, Beatrice
|b 23
700 1 _ |a Khaw, Kay-Tee
|b 24
700 1 _ |a König, Anna-Katharina
|b 25
700 1 _ |a Kupcinskas, Juozas
|b 26
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 27
700 1 _ |a Bambi, Franco
|b 28
700 1 _ |a Archibugi, Livia
|b 29
700 1 _ |a Mambrini, Andrea
|b 30
700 1 _ |a Cavestro, Giulia Martina
|b 31
700 1 _ |a Landi, Stefano
|b 32
700 1 _ |a Hegyi, Péter
|b 33
700 1 _ |a Izbicki, Jakob R
|b 34
700 1 _ |a Gioffreda, Domenica
|b 35
700 1 _ |a Zambon, Carlo Federico
|b 36
700 1 _ |a Tavano, Francesca
|0 0000-0002-8831-7349
|b 37
700 1 _ |a Talar-Wojnarowska, Renata
|b 38
700 1 _ |a Jamroziak, Krzysztof
|b 39
700 1 _ |a Key, Timothy J
|b 40
700 1 _ |a Fave, Gianfranco Delle
|b 41
700 1 _ |a Strobel, Oliver
|b 42
700 1 _ |a Jonaitis, Laimas
|b 43
700 1 _ |a Andriulli, Angelo
|b 44
700 1 _ |a Lawlor, Rita T
|b 45
700 1 _ |a Pirozzi, Felice
|b 46
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 47
700 1 _ |a Valsuani, Chiara
|b 48
700 1 _ |a Vashist, Yogesh K
|b 49
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 50
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 51
|e Last author
773 _ _ |a 10.1002/ijc.31928
|0 PERI:(DE-600)1474822-8
|n 6
|p 1275-1283
|t International journal of cancer
|v 144
|y 2019
|x 0020-7136
909 C O |p VDB
|o oai:inrepo02.dkfz.de:141291
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)20cdd3e2d3e6f8de7b2b90ab138c7a88
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)97343bbd9545a4b87574e74329dabfd1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)ac7a26c496af814293aa74ab92d5f5b3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)0a8ada1f5d2ea05fc3af10cd808bfa9a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 47
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 50
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 51
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2017
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l Klinische Epidemiologie und Alternsforschung
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 2
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 3
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21